Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Apr;56(4):279–284. doi: 10.1136/thorax.56.4.279

Adverse effects of oral corticosteroids in relation to dose in patients with lung disease

L Walsh 1, C Wong 1, J Oborne 1, S Cooper 1, S Lewis 1, M Pringle 1, R Hubbard 1, A Tattersfield 1
PMCID: PMC1746020  PMID: 11254818

Abstract

BACKGROUND—The adverse effects of oral corticosteroids are widely recognised but there are few quantitative data on which to base advice to patients. In a two part cross sectional study we compared adverse effects in patients with lung disease taking oral corticosteroids and control subjects and related the adverse effects to corticosteroid dose in the patient group.
METHODS—Data on oral corticosteroid use, lifestyle, fractures, and other possible adverse effects were collected by questionnaire and compared between a community based cohort of patients taking continuous or frequent intermittent oral corticosteroids for asthma, chronic obstructive pulmonary disease, or alveolitis and age and sex matched control subjects. Dose related effects were explored in the corticosteroid group using cumulative dose quartiles and multiple logistic regression.
RESULTS—A total of 367 patients (⩾50 years, 48% female) and 734 control subjects completed the questionnaire. The cumulative incidence of fractures since the time of diagnosis was 23% for patients taking oral corticosteroids and 15% in the control group (odds ratio (OR) 1.8; 95% confidence interval (CI) 1.3 to 2.6). Patients were more likely to have had a fracture of the vertebrae (OR 10; 95% CI 2.9 to 34), hip (OR 6; 95% CI 1.2 to 30), and ribs or sternum (OR 3.2, 95% CI 1.6 to 6.6) than control subjects. They also reported a significant increase in cataracts, use of antacids, muscle weakness, back pain, bruising, oral candidiasis, and having fewer teeth. The effects of oral corticosteroids were dose related: the odds ratio for patients in the highest compared with the lowest cumulative dose quartile (median prednisolone dose 61 g versus 5 g) ranged from 2 for all fractures to 9 for vertebral fractures and bruising.
CONCLUSIONS—By quantifying the morbidity associated with the use of oral corticosteroids, this study should help to rationalise their long term use.



Full Text

The Full Text of this article is available as a PDF (136.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSSON E., BRUUN E. Long-term treatment of bronchial asthma with steroid hormones. Acta Allergol Suppl (Copenh) 1960;7:275–283. [PubMed] [Google Scholar]
  2. Adinoff A. D., Hollister J. R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983 Aug 4;309(5):265–268. doi: 10.1056/NEJM198308043090502. [DOI] [PubMed] [Google Scholar]
  3. Baltzan M. A., Suissa S., Bauer D. C., Cummings S. R. Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. Lancet. 1999 Apr 17;353(9161):1327–1327. doi: 10.1016/s0140-6736(98)04835-1. [DOI] [PubMed] [Google Scholar]
  4. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995 Jan;54(1):49–52. doi: 10.1136/ard.54.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dolan P., Torgerson D. J. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int. 1998;8(6):611–617. doi: 10.1007/s001980050107. [DOI] [PubMed] [Google Scholar]
  6. Fitzsimons R., Grammer L. C., Halwig J. M., Aksamit T., Patterson R. Prevalence of adverse effects in corticosteroid dependent asthmatics. N Engl Reg Allergy Proc. 1988 Mar-Apr;9(2):157–162. doi: 10.2500/108854188778994922. [DOI] [PubMed] [Google Scholar]
  7. Hubbard R., Lewis S., Richards K., Johnston I., Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet. 1996 Feb 3;347(8997):284–289. doi: 10.1016/s0140-6736(96)90465-1. [DOI] [PubMed] [Google Scholar]
  8. Kankaala T. M., Virtanen J. I., Larmas M. A. Timing of first fillings in the primary dentition and permanent first molars of asthmatic children. Acta Odontol Scand. 1998 Feb;56(1):20–24. doi: 10.1080/000163598423018. [DOI] [PubMed] [Google Scholar]
  9. Kwong F. K., Sue M. A., Klaustermeyer W. B. Corticosteroid complications in respiratory disease. Ann Allergy. 1987 May;58(5):326–330. [PubMed] [Google Scholar]
  10. Kässer U. R., Gleissner C., Dehne F., Michel A., Willershausen-Zönnchen B., Bolten W. W. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum. 1997 Dec;40(12):2248–2251. doi: 10.1002/art.1780401221. [DOI] [PubMed] [Google Scholar]
  11. LIVINGSTONE J. L., DAVIES J. P. Steroids in the long-term treatment of asthma. Lancet. 1961 Jun 17;1(7190):1310–1314. doi: 10.1016/s0140-6736(61)90238-0. [DOI] [PubMed] [Google Scholar]
  12. Lieberman P., Patterson R., Kunske R. Complications of long-term steroid therapy for asthma. J Allergy Clin Immunol. 1972 Jun;49(6):329–336. doi: 10.1016/0091-6749(72)90131-5. [DOI] [PubMed] [Google Scholar]
  13. Pearce N. What does the odds ratio estimate in a case-control study? Int J Epidemiol. 1993 Dec;22(6):1189–1192. doi: 10.1093/ije/22.6.1189. [DOI] [PubMed] [Google Scholar]
  14. Peel N. F., Moore D. J., Barrington N. A., Bax D. E., Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis. 1995 Oct;54(10):801–806. doi: 10.1136/ard.54.10.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. REES H. A., WILLIAMS D. A. Long-term steroid therapy in chronic intractable asthma. A study of 317 adult asthmatics on continuous steroid therapy for an average period of 2 1/2 years. Br Med J. 1962 Jun 9;1(5292):1575–1579. doi: 10.1136/bmj.1.5292.1575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sambrook P., Birmingham J., Kempler S., Kelly P., Eberl S., Pocock N., Yeates M., Eisman J. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990 Dec;5(12):1211–1216. doi: 10.1002/jbmr.5650051204. [DOI] [PubMed] [Google Scholar]
  17. Verstraeten A., Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986 Oct;45(10):852–857. doi: 10.1136/ard.45.10.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Walsh L. J., Wong C. A., Pringle M., Tattersfield A. E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996 Aug 10;313(7053):344–346. doi: 10.1136/bmj.313.7053.344. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES